Treatment of Hepatitis C Virus-Associated Mixed Cryoglobulinemia with Sofosbuvir-Based Direct-Acting Antiviral Agents

BACKGROUND: Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome (MCS). The efficacy and safety of all-oral directly-acting antiviral (DAA) therapy in HCV-associated MCS (HCV-MCS) is largely unknown. METHODS: Case series of patients with HCV-MCS who were treated with s...

Full description

Saved in:
Bibliographic Details
Published in:Hepatology
Main Authors: Sise, Meghan E., Bloom, Allyson K., Wisocky, Jessica, Lin, Ming V., Gustafson, Jenna L., Lundquist, Andrew L., Steele, David, Thiim, Michael, Williams, Winfred W., Hashemi, Nikroo, Kim, Arthur Y., Thadhani, Ravi, Chung, Raymond T.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718772/
https://ncbi.nlm.nih.gov/pubmed/26474537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28297
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items